Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.660
-0.350 (-6.99%)
At close: Aug 10, 2026, 4:00 PM EDT
4.670
+0.010 (0.21%)
Pre-market: Aug 11, 2026, 7:47 AM EDT

Lifecore Biomedical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Lifecore Biomedical stock has a consensus rating of "Buy" and an average price target of $6.75. The average 1-year stock price forecast is 44.85% higher than the current stock price, while the lowest is $5.00 (+7.30%) and the highest is $9.00 (+93.13%).

Price Target: $6.75 (+44.85%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$6.75$6.25$9.00
Change+7.30%+44.85%+34.12%+93.13%

Analyst Ratings

The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222222
Buy111111
Hold222222
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aAug 11, 2026
Barrington
Barrington
Buy
Maintains
$6.5$6.25
BuyMaintains$6.5$6.25+34.12%Aug 6, 2026
KeyBanc
KeyBanc
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 6, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 6, 2026
Stephens
Stephens
Hold
Reiterates
$8.5$5
HoldReiterates$8.5$5+7.30%Mar 17, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
121.43M
from 128.87M
Decreased by -6.21%
Revenue Next Year
130.28M
from 121.43M
Increased by 7.29%
EPS This Year
-0.89
from -0.43
EPS Next Year
-0.82
from -0.89
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2025FY 2026
Period EndingMay 29, 2022May 28, 2023May 26, 2024May 25, 2025Dec 31, 2025Dec 31, 2026
Revenue
111.27M103.27M128.26M128.87M129.46M121.43M
Revenue Growth
10.31%-7.19%24.20%0.47%0.46%-6.21%
Gross Profit
39.07M27.99M41.85M40.30M40.61M36.67M
Gross Margin
35.11%27.10%32.63%31.27%31.37%30.20%
Operating Income
-3.43M-19.72M-5.49M-12.01M-1.26M4.83M
Net Income
-116.72M-99.56M12.01M-38.72M-30.79M-38.92M
EPS
-----0.43-0.89
Free Cash Flow
-26.82M16.29M-20.27M-29.04M-9.34M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High123.3M
Avg121.4M
Low120.0M

Revenue Growth

Revenue Growth202620272028
High
-4.7%
Avg
-6.2%
Low
-7.3%

EPS Forecast

EPS202620272028
High-0.81
Avg-0.89
Low-0.97

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-